Skip to main content
. 2011 Apr 18;119(8):1070–1076. doi: 10.1289/ehp.1002741

Figure 1.

Figure 1

F1 female mammary gland development. Mammary whole-mounts illustrate morphology representative of treatment groups at PNDs 22, 42, and 63 (n = 6–7 females/treatment/age). Bars = 1,000 μm for PND22 and 2,000 μm for PND42 and PND63.